Evaluated by: David B. Kaminsky, M.D., FIAC, February 22, 2018
Original release date: April 18, 2018
Access to this course expires on: February 22, 2021, at 11:59 PM Pacific Time
Many pathologists are unfamiliar with a variety of entities in lung, pleural, mediastinal and transplant pathology. The potential for diagnostic error in these areas relates to inexperience from restricted exposure or caseload. Drs. Tazelaar and Churg’s interactive microscopy course with an expert faculty is designed to close this practice gap by providing a comprehensive but detailed look at fibrosing interstitial pneumonias, pulmonary vasculitis, and some forms of pulmonary infection; benign and malignant mesotheliomas; thymomas and other mediastinal lesions; pulmonary tumors using cytology; and lung/heart/liver transplant rejection and their mimics. The simulated sign-out format confers a mentoring opportunity for interactive learning, promoting dialogue and exchange of criteria, common challenges, and differential diagnoses. The ultimate goal is the optimization of patient outcomes.
Practicing academic and community pathologists, and pathologists-in-training
Upon completion of this educational activity, learners will be able to:
Continuing Medical Education and Continuing Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 14.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 14.75 SAM/Part II credit hours.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reporting relevant financial relationships: Henry D Tazelaar, M.D.: Consultant, Paraxel Inc.; Speaker, Cipla Ltd
The following faculty reported no relevant financial relationships: Andrew Churg, M.D., Ph.D., Rish K. Pai, M.D., Ph.D., Anja C. Roden, M.D., Maxwell L. Smith, M.D., Ph.D., Maureen F. Zakowski, M.D.
The following IM Coordinators reported no relevant financial relationships: David B. Kaminsky, MD, FIAC and Laura Lamps, MD
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.
Buy the entire Pathology of the Lung, Pleura, Mediastinum, and Heart/Liver/Lung Transplantation course and get a great discount!
Not A Member? Click Here